- $2.68bn
- $2.24bn
- $1.34bn
- 99
- 55
- 65
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,014 | 873 | 1,032 | 1,194 | 1,337 |
Cost of Revenue | |||||
Gross Profit | 952 | 816 | 954 | 1,088 | 1,223 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 979 | 912 | 1,000 | 1,135 | 1,258 |
Operating Profit | 35.5 | -38.8 | 31.5 | 58.4 | 79 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 49.8 | -35.1 | 33.7 | 66.8 | 105 |
Provision for Income Taxes | |||||
Net Income After Taxes | 40.9 | -19.4 | 39.7 | 36.3 | 99.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 40.9 | -19.4 | 39.7 | 36.3 | 99.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 40.9 | -19.4 | 39.7 | 36.3 | 99.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.524 | -0.232 | 0.505 | 0.573 | 1.79 |